Daniel E. Bauer

Harvard Medical School

Affiliated withHarvard Medical School Boston Children's Hospital Dana-Farber Cancer Institute

Research Area

Biography

Daniel E. Bauer has not added Biography.
If you are Daniel E. Bauer and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 159	2015

Other Publications

Article	Year
Safety and immunogenicity of ALVAC vCP1452 and recombinant gp160 in newly human immunodeficiency virus type 1-infected patients treated with prolonged highly active antiretroviral therapy. Journal of virology\| PubMed ID: 11836398	2002
Bcl-x(L) complements Saccharomyces cerevisiae genes that facilitate the switch from glycolytic to oxidative metabolism. The Journal of biological chemistry\| PubMed ID: 12244097	2002
Alkylating DNA damage stimulates a regulated form of necrotic cell death. Genes & development\| PubMed ID: 15145826	2004
Akt stimulates aerobic glycolysis in cancer cells. Cancer research\| PubMed ID: 15172999	2004
Cytokine stimulation of aerobic glycolysis in hematopoietic cells exceeds proliferative demand. FASEB journal : official publication of the Federation of American Societies for Experimental Biology\| PubMed ID: 15180958	2004
Growth factor regulation of autophagy and cell survival in the absence of apoptosis. Cell\| PubMed ID: 15680329	2005
The glucose dependence of Akt-transformed cells can be reversed by pharmacologic activation of fatty acid beta-oxidation. Oncogene\| PubMed ID: 15806154	2005
ATP citrate lyase is an important component of cell growth and transformation. Oncogene\| PubMed ID: 16007201	2005
ATP citrate lyase inhibition can suppress tumor cell growth. Cancer cell\| PubMed ID: 16226706	2005
BRD4-NUT carcinoma of the mediastinum in a pediatric patient: multidetector computed tomography imaging findings. Journal of thoracic imaging\| PubMed ID: 20395873	2010
Update on fetal hemoglobin gene regulation in hemoglobinopathies. Current opinion in pediatrics\| PubMed ID: 21157349	2011
Differentiation of NUT midline carcinoma by epigenomic reprogramming. Cancer research\| PubMed ID: 21447744	2011
Loss-of-function and gain-of-function phenotypes of stomatocytosis mutant RhAG F65S. American journal of physiology. Cell physiology\| PubMed ID: 21849667	2011
Clinicopathologic features and long-term outcomes of NUT midline carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 22896655	2012
Reawakening fetal hemoglobin: prospects for new therapies for the Î²-globin disorders. Blood\| PubMed ID: 22904296	2012
Cyclin D3 coordinates the cell cycle during differentiation to regulate erythrocyte size and number. Genes & development\| PubMed ID: 22929040	2012
Combinatorial assembly of developmental stage-specific enhancers controls gene expression programs during human erythropoiesis. Developmental cell\| PubMed ID: 23041383	2012
Corepressor-dependent silencing of fetal hemoglobin expression by BCL11A. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 23576758	2013
An erythroid enhancer of BCL11A subject to genetic variation determines fetal hemoglobin level. Science (New York, N.Y.)\| PubMed ID: 24115442	2013
Characterization of genomic deletion efficiency mediated by clustered regularly interspaced palindromic repeats (CRISPR)/Cas9 nuclease system in mammalian cells. The Journal of biological chemistry\| PubMed ID: 24907273	2014
TMEM14C is required for erythroid mitochondrial heme metabolism. The Journal of clinical investigation\| PubMed ID: 25157825	2014